Industry

Patient, doctor, health system affect glaucoma drop compliance

Healio Optometry1d ago1 min read

Patient adherence to glaucoma drop treatment regimens is a well-known barrier to disease management, but a study published in Optometry and Vision Science also recognized clinician practice and health system structures.Patients and practitioners interviewed cited issues with medication availability, disruptions to routines, time constraints and lack of clinical resources.“As the global burden of glaucoma increases, addressing medication adherence represents a critical and potentially modifiable determinant of improving clinical, social and economic outcomes,” Deborah Bott, PhD, of

Read full article on Healio Optometry

AI Summary

Quick Take

A study in Optometry and Vision Science reveals that glaucoma medication non-adherence is driven by clinician practice and health system structures as much as patient behavior. Key barriers identified include medication availability, clinical time constraints, and a lack of resources, suggesting that adherence is a modifiable systemic issue rather than just a patient-level failure.

Why It Matters

For years, the industry has focused on patient education and reminders, yet adherence rates remain stubbornly low. This study reframes the conversation by acknowledging that the environment we practice in—and the systems our patients navigate—are often designed in ways that hinder compliance. If we want to improve clinical outcomes and reduce the economic burden of glaucoma, we must address these structural friction points, such as pharmacy stock issues and the limited time clinicians have for patient interaction, rather than placing the burden solely on the patient.

Key Findings

Medication adherence is influenced by a triad of factors: the patient, the clinician's practice patterns, and the overarching health system structure.
Practitioners and patients both identified medication availability and disruptions to daily routines as primary obstacles to consistent drop use.
Time constraints within the clinical setting were cited as a major barrier to effectively managing and monitoring patient adherence.
The study suggests that addressing these systemic factors is a critical, modifiable step toward improving social and economic outcomes related to glaucoma.

Study Snapshot

Design

Qualitative interview-based study

Population

Glaucoma patients and practitioners

Practice Implications

Clinicians should look beyond patient forgetfulness and screen for systemic barriers such as pharmacy access issues or routine changes. Practice owners may need to reconsider appointment structures to allow more time for addressing these practical hurdles to treatment success.

Who's Affected

OptometristsOphthalmologistsGlaucoma SpecialistsPractice Owners

Evidence StrengthModerate

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.